Literature DB >> 12942491

Augmentation of the amplitude of electrocardiographic QRS complexes immediately after hemodialysis: a study of 26 hemodialysis sessions of a single patient, aided by measurements of resistance, reactance, and impedance.

John E Madias1, Virenjan Narayan.   

Abstract

An increase in the amplitude of electrocardiogram QRS complexes ( upward arrow QRS) with hemodialysis (HD) has been invariably documented, but the relationship with weight loss has varied, and other parameters (ie, hemoglobin, body electrical properties), which could be determinants of upward arrow QRS, have not all been evaluated in the same patients. We investigated a patient immediately before and after 26 sessions of HD with measurements of a host of variables. Statistically significant correlations were found only between weight loss and net fluid removed (r =.72, P =.0005), and percentage change in the sums of QRS complexes of all 12-electrocardiogram leads and weight lost during HD (r =.41, P =.038). HD imparts a reproducible upward arrow QRS, but variation in all the other intercorrelations can be attributed to the complexity of the procedure and its variable impact on many body parameters.

Entities:  

Mesh:

Year:  2003        PMID: 12942491     DOI: 10.1016/s0022-0736(03)00050-5

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  15 in total

1.  Relations between respiratory changes in R-wave amplitude and arterial pulse pressure in mechanically ventilated patients.

Authors:  Maxime Cannesson; Geoffray Keller; Olivier Desebbe; Jean-Jacques Lehot
Journal:  J Clin Monit Comput       Date:  2010-05-11       Impact factor: 2.502

2.  Hormones, fluid retention, and ST segment changes.

Authors:  John E Madias
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

3.  Increases in P-wave duration and dispersion after hemodialysis are totally (or partially) due to the procedure-induced alleviation of the body fluid overload: a hypothesis with strong experimental support.

Authors:  John E Madias
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

4.  Determinants of augmentation of ECG QRS complexes and R waves in patients after hemodialysis.

Authors:  Abdenasser Drighil; John E Madias; Hanane El Mosalami; Nadia El Badaoui; Ahmed Bennis; Bahija Mouine; Wafae Fadili; Beenyouness Ramdani
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

Review 5.  The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease.

Authors:  Sofia Skampardoni; Dimitrios Poulikakos; Marek Malik; Darren Green; Philip A Kalra
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

6.  Theories and Controversies on Mechanism of Electrocardiographic Changes during Hemodialysis: Reply to Christov et al.

Authors:  Ramazan Astan; Ozcan Ozeke
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03       Impact factor: 1.468

7.  Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis.

Authors:  Jonathan W Waks; Larisa G Tereshchenko; Rulan S Parekh
Journal:  J Electrocardiol       Date:  2016-07-28       Impact factor: 1.438

8.  Amplitude of the electrocardiographic QRS complexes during and after severe pulmonary edema.

Authors:  John E Madias
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

9.  Augmentation of ECG QRS complexes after fluid removal via a mechanical ultrafiltration pump in patients with congestive heart failure.

Authors:  John E Madias; Maya E Guglin
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

10.  The effect of hemodialysis on electrocardiographic parameters.

Authors:  Ramazan Astan; Ibrahim Akpinar; Adnan Karan; Fehmi Kacmaz; Erdogan Sokmen; Erkan Baysal; Ozcan Ozeke; Mehmet Timur Selçuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-09       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.